Towa Pharmaceutical Co Ltd 2024 Integrated Report
Company: Towa Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 60
The report presents Towa Group's FY2023 performance and integrated value-creation priorities, including stable supply and quality assurance, sustainability governance, group-wide climate analysis, emissions objectives, and employee health and development. It reports consolidated FY2023 net sales of JPY 227,934 million and 4,588 consolidated employees, while describing the expansion of TCFD analysis to all domestic and overseas Group operations. Human-capital highlights include a Human Resource Development Center, career support, diversity initiatives, and recognition as a Health & Productivity Management Outstanding Organization 2024.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.